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Protein translocationacross theendoplasmic reticulummem-
brane occurs at the Sec61 translocon. This has two essential
subunits, the channel-forming multispanning membrane pro-
tein Sec61p/Sec61 and the tail-anchored Sss1p/Sec61, which
has been proposed to “clamp” the channel. We have analyzed
the function of Sss1p using a series of domain mutants and
found that both the cytosolic and transmembrane clamp
domains of Sss1p are essential for protein translocation. Our
data reveal that the cytosolic domain is required for Sec61p
interaction but that the transmembrane clamp domain is
required to complete activation of the translocon after precur-
sor targeting to Sec61p.
The translocon is a highly conserved protein complex that
forms a channel for the translocation of proteins across the
endoplasmic reticulum (ER)2 membrane. It is a heterotrimer
consisting of Sec61p/Sec61, Sss1p/Sec61, plus the nonessen-
tial Sbh1p/Sec61 subunit and is both structurally and func-
tionally homologous to the plasma membrane SecYEG and
SecYE complexes found in eubacteria and archaea, respec-
tively (1). Analysis of SecYE and SecYEG complexes at high
resolution has identified a number of key structural features
and led to a general model for translocon function (2, 3). In this
model, the SecY/Sec61p/Sec61 subunit (-subunit) forms a
transmembrane protein-conductive channel with a “plug”
domain located on the luminal side of a central narrow con-
striction in the closed state, which upon channel activation is
predicted to move toward the periplasm/ER lumen. A lateral
gate formed by TM domains 2b and 7 of the -subunit is pro-
posed to interact with signal sequences to allow their partition
into the membrane bilayer. The SecE/Sss1p/Sec61 subunit
(-subunit) is located at the channel periphery and has a long
curved TM domain that traverses the membrane diagonally. It
contacts both the N (TM1–5) and C (TM6–10) halves of the
-subunit and has been proposed to act as a “clamp” to hold
both halves of the SecY/Sec61 together, thus regulating lateral
access to the translocation channel (2). This elegantmodel pre-
dicts an important role for Sss1p in regulating the yeast ER
translocon, and we have sought to test this both in vivo and in
vitro. We have constructed a series of novel mutations in Sss1p
and used these to examine the roles of both the cytosolic and
TM clamp domains in translocon function. The phenotypes of
thesemutants show that both the cytosolic domain and the TM
domain are essential for protein translocation. In addition we
show that the TM domain is required for Sss1p membrane asso-
ciation but that the cytosolic domain is essential for interaction
with Sec61p and specificallywith Sec61pTM9. Substitution of the
TM clamp domain with the TM region of another ER tail-an-
chored protein resulted in a Sss1p mutant that could associate
efficiently with Sec61p but was unable to support translocation in
vivo. This translocation defectwas reconstituted in vitrowherewe
usedsite-specificcross-linking toreveal thatprecursorproteinwas
efficiently targeted to Sec61p in this context but was unable to
progress beyond this step. Our results demonstrate that Sss1p is
required after signal sequence interaction with the translocon to
complete channel activationand that the clampdomainofSss1p is
a key regulator of translocon function.
EXPERIMENTAL PROCEDURES
Growth of Yeast Cells—Yeast strains (Table 1) were grown at
30 °C in YP medium (2% peptone, 1% yeast extract) containing
2% glucose and 0.02% adenine (YPAD) or in minimal medium
(0.67% yeast nitrogen base) with 2% glucose or galactose with
appropriate supplements for selective growth. For glucose
repression, cells were grown in minimal galactose medium to
an A600 nm 0.2, harvested, and resuspended in YPAD at the
same density. For methionine repression, cells were similarly
transferred from methionine-free to medium containing 2 mM
methionine. Solid media were supplemented with 2% agar.
Yeast transformation and 5-fluoroorotic acid (5-FOA) coun-
terselection of URA3 plasmids have been previously described
(7). All growth medium was purchased from Difco Laborato-
ries. Geneticin and 5-FOA were fromMelford Laboratories.
Constructionof SSS1Mutations—SSS1wasclonedona1136-bp
SalI/SspI fragment from FKp52 (4) into SalI/EcoRV-digested
pRS313 (8). The resulting plasmid (pJKB2) was used for site-di-
rected mutagenesis (QuikChange, Stratagene) to create the G57L
mutation (primers SSS1-G1, G1a: see supplementary Table S1 for
primer sequences). The G62L mutation (primers SSS1-G2, G2a)
was introduced into the G57L plasmid, and this G57L/G62L dou-
blemutationwas used in turn to add theG65Lmutation (primers
SSS1-G3, G3a) and hence generate the G57L/G62L/G65L triple
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mutation. A stop codon was inserted after the SSS1 Lys52 codon
(primers SSS1-C,Ca) in pJKB2 to produce a construct express-
ing the Sss1p TM deletion (Sss1Cp). A product including the
UBC6 promoter and the cytosolic domain sequences (residues
Met1–Ser232) followed by a BamHI site was generated by PCR
(primers UBC6–1, -3) from Saccharomyces cerevisiae genomic
DNA. A fragment encoding the C-terminal region of SSS1 (resi-
dues 53–80) and transcription termination sequences preceded
by a BamHI site was produced by PCR (primers; SSS1–1, 4) from
FKp52.The twoPCRproductswere digestedwithBamHI, ligated,
end-filled, and subsequently ligated into SmaI-digested pRS313
generating a plasmid encoding the USCp fusion. A fragment
encoding theTMofUbc6p (residuesMet233–Met249) precededby
a BamHI site and followed by SSS1 sequences starting from the
Lys69 codonwasgeneratedbyPCRusingFKp52 (primersUSSS1C,
Ca). The product was digested with BamHI and Ssp1, ligated into
BamHI/Ssp1-digested pJKB2 derivative with a BamHI site
inserted immediately after the K52 codon to generate the NSUp
fusion plasmid pBW236. The sequences of all mutations and con-
structs generated by PCR were verified by DNA sequencing. A
774-bp SalI/SmaI fragment from pBW236 encoding the NSUp
fusion was cloned into pRS316 (8) to provide low copy expression
on aURA3 vector (pBW252). Similarly, a 1140-bp SalI/EcoRI SSS1
encoding a fragment from pJKB2 was cloned into pRS316 to gen-
erate pBW249. These pRS316 based plasmids were used for
CMY28 (Table 1) transformation.
Other SSS1 Plasmids—Aplasmid expressing SEC61 and SSS1
(pCM203; CEN, URA3) was generated by ligation of a 7.7-kb
Sma1/XhoI fragment of pBW7 (6) with a 1.8-kb SalI/SmaI
SSS1-encoding fragment of FKp52 (4). The MET3-SSS1 plas-
mid (pCM214;CEN,TRPI) was constructed as follows. A 1.8-kb
SalI/EcoRI fragment encoding SSS1 was isolated from FKp52
and ligated into SalI/EcoRI-digested pRS314 (8). A uniqueNdeI
site was then inserted immediately upstream of the SSS1 ATG
start codon (primers SSS1-NdeIF, NdeIR) by site-directed
mutagenesis. The resulting plasmidwas digestedwithNdeI and
end-filled byKlenow treatment. This product was SalI-digested
to excise the SSS1 promoter, which was replaced with aMET3
promoter generated by BamHI digestion, end-filling with Kle-
now and then SalI digestion of pJT31 (9).
Construction of the Sec61-tmd9CCC Plasmid—The three
endogenous cysteine codons of SEC61 (Cys121, Cys150, and
Cys373) were changed to alanine codons by site-directed
mutagenesis (primers SEC61-121-SEC61-373a) of a pBW11
derivative (CEN, SEC61, LEU2) plasmid containing a BamHI
site at nucleotides 532–537 of the SEC61 ORF (10). This was
used as a template to convert the three consecutive codons
Ala423, Phe424, and Gly425 in TM9 (primers SEC61tm9C,Ca) to
cysteine codons to generate the functional sec61-tmd9CCC
allele expressed on plasmid pCM108.
Yeast Strain Construction—The sss1::KanMX4 null muta-
tion was made by PCR amplification (primers-sss1-1, 1a) of
the pFA6a-kanMX4module (11), and transformation of strain
W303-2n (Table 1) to Geneticin resistance. Correct integration
of sss1::kanMX4 was confirmed by PCR analysis of genomic
DNA. The SSS1/sss1 strain, BWY529, was transformed with
the SSS1,URA3 plasmid FKp53 (4), sporulated, and tetrad-dis-
sected on YPAD medium. Geneticin-resistant Ura colonies
consistentwith rescue of the lethalsss1phenotype by the plas-
mid were obtained. One of these, BWY530, was used for the
shuffle of sss1 mutant alleles on 5-FOA medium. A MATa
equivalent, BWY531, was crossed with BWY12, and the result-
ing diploid was transformedwith pCM203, sporulated, and tet-
rad-dissected on YPAD medium to yield the sss1/sec61
strain CMY5. CMY28 was derived by transformation of CMY5
jointly with pCM108 and pCM214, followed by passage on
5-FOAmedium. The sss112::kanMX6 allele wasmade by PCR
amplification of a pFA6a-GFP(S65T)-kanMX6 module (11)
designed to truncate Sss1p after residue Ile68. It was used to
transform W303-2n (Table 1) to Geneticin resistance. The
resulting SSS1/sss112::kanMX6 transformant was confirmed
by PCR analysis of genomic DNA. It was transformed with
FKp53 (4), sporulated, and tetrad-dissected on YPADmedium.
Geneticin-resistant Ura colonies were unable to grow on
5-FOA medium. One of these colonies and BWY530 were
transformed with pCM214, followed by growth on 5-FOA
medium lacking methionine to generate strains BWY875
(sss1) and BWY886 (sss112) rescued by the MET3-SSS1
allele.
Cell Extract Preparation and Immunoblotting—Yeast whole
cell extracts were prepared from 5.0 A600 nm units of exponen-
tially growing cells by suspension in sample buffer with 0.5-mm
glass beads and disruption at 6.5 M/s for 30s (Hybaid Ribolyser).
The samples were incubated for 5 min at 65 °C, then 5 min at
95 °C. After SDS-PAGE, proteins were electroblotted to PVDF
membranes (Millipore), and antibody incubations were per-
formed as previously described (7). Antisera recognizing the C
terminus of Sec61p (12), Sbh1p (13), DPAPB (7), Kar2p (9), and
TABLE 1
Yeast strains used in this article
Strain Genotype Reference
FKY198 MAT, ade2-1, ura3-1, his3-11,-15, leu2-3,-112, trp1-1, CAN1-100, sss1::URA3, pep4::LEU2, pGAL10::SSS1,
ADE2
4
W303-2n MATa/MAT, ade2-1/ade2-1, ura3-1/ura3-1, his3-11,-15/his3-11,-15, leu2-3,-112/leu2-3,-112, trp1-1/trp1-1,
CAN1-100/CAN1-100
5
BWY12 MAT, sec61::HIS3, ade2-1, ura3-1, his3-11,-15, leu2-3,-112, trp1-1, CAN1-100, pBW7 6
BWY529 MATa/MAT, SSS1/sss1::KanMX4, ade2-1/ade2-1, ura3-1/ura3-1, his3-11,-15/his3-11,-15, leu2-3,-112/leu2-3,
trp1-1/trp1-1, CAN1-100/CAN1-100
This study
BWY530 MAT, sss1::KanMX4, ade2-1, ura3-1, his3-11,-15, leu2-3,-112, trp1-1, CAN1-100, FKp53 This study
BWY531 MATa, sss1::KanMX4, ade2-1, ura3-1, his3-11,-15, leu2-3,-112, trp1-1, CAN1-100, FKp53 This study
BWY875 MATa, sss1::KanMX4, ade2-1, ura3-1, his3-11,-15, leu2-3,-112, trp1-1, CAN1-100, pCM214 This study
BWY886 MATa, sss112::KanMX6, ade2-1, ura3-1, his3-11,-15, leu2-3,-112, trp1-1, CAN1-100, pCM214 This study
CMY5 MAT, sss1::KanMX4, sec61::HIS3, ade2-1, ura3-1, his3-11,-15, leu2-3,-112, trp1-1, CAN1-100, pCM203 This study
CMY28 MAT, sss1::KanMX4, sec61::HIS3, ade2-1, ura3-1, his3-11,-15, leu2-3,-112, trp1-1, CAN1-100,
pCM214/pCM108
This study
Role of Sss1p in ER Protein Translocation
32672 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 285 • NUMBER 42 • OCTOBER 15, 2010
Sec62p, Sec63p, and ppCPY (14) have been described. Antisera
against Sss1p andUbc6p were raised in sheep by immunization
using antigens consisting of residues 1–52 and 1–228, respec-
tively, which had been purified by His tag affinity purification.
Cellular Fractionation and Carbonate Extraction of Mem-
branes—For cellular fractionation, 50A600 nm units of exponen-
tially growing cells were harvested, washed in distilled water,
and resuspended in 0.5ml of ice-cold lysis buffer (0.2 M sorbitol,
20 mMHEPES, pH 7.4, 50 mM KOAc, 5 mM EDTA, 1 mM DTT,
10 g/ml each leupeptin/aprotinin, 5 g/ml each chymostatin/
pepstatin). The cells were broken by glass bead lysis. The lysate
was removed from the beads and subjected to centrifugation at
100,000  g for 30 min at 4 °C with the supernatant providing
the cytosolic fraction and the pellet providing the membrane
fraction. For carbonate extraction, membrane preparations
(10) were mixed with 4 volumes of 125 mM Na2CO3, pH 11.5,
and left on ice for 30 min. The samples were then subjected to
centrifugation at 100,000  g for 30 min at 4 °C. The pellet that
was solubilized in SDS-PAGE sample buffer provided the car-
bonate-resistant fraction, whereas the soluble fraction that was
subjected to precipitationwith 10% trichloroacetic acid provid-
ing the carbonate-soluble fraction.
Phenanthroline Oxidation—Phenanthroline was activated
by mixing 1 volume of 240 mM CuSO4 with 2 volumes of 360
mM1,10-phenanthroline (prepared in 50% ethanol) followed by
12-fold dilution in aqueous solution. Membranes were treated
with 2 mM Cu2(phe)3 at 30 °C for 20 min, with quenching by
the addition of neocuproine to 25 mM for 5 min. Membranes
were prepared as previously described (7).
Radiolabeling and Immunoprecipitation—[35S]Methionine/
cysteine (PerkinElmer Life Sciences) labeling of yeast cells was
performed as described previously (7). Briefly, 5.0 A600 nm
equivalents of cleared cell extract were added to saturating
amounts of antiserum followed by rotation for 2 h at room
temperature. Immune complexes were bound to protein
A-Sepharose beads (Sigma) at room temperature for a further
2 h. Beads were washed three times with immunoprecipitation
buffer, and antigens were disassociated in SDS-PAGE sample
buffer. 14C-Amino acid (PerkinElmer Life Sciences) labeling of
yeast cells was similarly performed (14). After SDS-PAGE,
dried gels were analyzed with a Fuji BAS3000 PhosphorImager.
InVitroTranslation,MembraneTranslocation, andPhotocross-
linking—A lysine codon was substituted at position 14 of a K5
ppF construct (15). The resulting K5/K14-ppF species was
transcribed (PromegaT7 express) and then translated in reticu-
locyte lysate (Promega) for 1 h at 30 °C in the presence of
[35S]methionine and 4-(3-trifluoromethyldiazarino) benzoic
acid (TDBA)-lysyl-tRNA (15) in the dark. After the addition of
cycloheximide to 1 mM, ribosomes were removed by centrifu-
gation at 400,000  g for 20 min before use. For translocation
reactions, 10 l of a K5/K14-ppF translation were mixed with
0.2 A280 nm units of yeast membranes in a final volume of 20 l
with a 20-min incubation at 20 °C. For the targeting assay, 100
l of K5/K14-ppF translation and 2.0 A280 nm units of mem-
branes were ATP-depleted (15), mixed with a 20-min incuba-
tion at 20 °C. Themembranes were pelleted at 20,000 g for 10
min followed by resuspension in 100 l of membrane buffer.
Two-thirds were UV-irradiated (UVP spot cure emitting 254–
365nm, 800mW/cm2) on ice for 2 s, the remaining third kept on
ice in the dark.
RESULTS
Cytosolic and Transmembrane Domains Are Essential for
Sss1p Function—Sss1p is a small C-terminal anchor protein
and in the simplest analysis consists of an N-terminal cytosolic
domain (residuesMet1–Asp46) and aC-terminal TMdomain of
28 residues (Tyr47–ILe75, Fig. 1A). Structural analysis has
shown that the cytosolic domain is in close proximity to the
C-terminal half of Sec61p and has a specific contact with the
cytosolic region of Sec61p between TM6 and TM7, whereas
the Sss1p TM contacts TM 1, 5, 6, and 10 of Sec61p (Fig. 1B).
The role of the TM was initially addressed by mutation of con-
served TM residues identified by inspection of Sss1p/Sec61
protein sequences from various species (Fig. 1A). Three highly
conserved glycine residues equating to glycine residues 57, 62,
and 65 of Sss1p were changed to leucine to assess their role in
Sss1p function. However, no growth or ER translocation
defects were evident in cells bearing these mutations (see
supplemental Fig. S1).
The lack of phenotypes uponmutation of residues in the TM
raised the possibility that this domainwas dispensable for Sss1p
function. This was addressed by generating a deletionmutation
expressing the N-terminal 52 residues of Sss1p (Sss1Cp) thus
lacking the TM (Fig. 1C). However, this TM deletion mutation
was unable to complement the lethal sss1mutation (Fig. 1D),
indicating that the cytosolic domain alone was nonfunctional
either due to a defect in ER membrane localization or because
the TM domain has a function in addition to that of a mem-
brane anchor. This was tested by replacing 16 residues
(Lys53–Ile68) of the Sss1p TM, including the conserved gly-
cine residues and also encompassing the region interacting
with Sec61p TM5 and TM10 (Fig. 1B) with the TM domain
of the ER C-terminal anchor protein, Ubc6p. The resulting
fusion protein “NSUp,” containing the N terminus of Sss1p
and the Ubc6p TM (Fig. 1C), was also unable to complement
the null mutation (Fig. 1D), suggesting a critical role for the
Sss1p TM domain. Perhaps not surprisingly, when the func-
tion of the Sss1p cytsosolic domain was tested by analyzing a
fusion of the cytosolic domain of Ubc6p to the Sss1p C ter-
minus, “USCp” (Fig. 1C), it was also unable to complement
(Fig. 1D), showing that this domain is also essential for Sss1p
function.
Expression of Sss1p Mutant Proteins—We next tested the
expression and membrane association of the Sss1p domain
mutant proteins in the yeast strain FKY198 which enables the
analysis of nonfunctional sss1 mutations. This strain, which is
grown in galactosemediumbut is inviable upon glucose repres-
sion of theGAL10-SSS1 allele (4), was transformedwith control
andmutant plasmids. Immunoblot analysis of total cell extracts
from transformants grown in galactose and glucose medium
was performed (Fig. 2A). The expression of Sss1p was largely
abolished after 6 h in glucose medium in the vector-trans-
formed control cells (Fig. 2A, lanes 3 and 4), compared with the
continued expression of Sss1p in cells transformed with
the wild-type SSS1 plasmid (Fig. 2A, lane 2). Cells carrying the
Sss1Cp plasmid expressed a novel faster migrating species
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corresponding to the truncated derivative of Sss1p (Fig. 2A,
lanes 5 and 6). The NSU protein was expressed as a species
migrating very similar in size to Sss1p (Fig. 2A, lanes 2 and 8),
whereas the USC protein was detected as a novel species
migrating slower than Ubc6p (Fig. 2B, lane 2).
The membrane association of Sss1Cp was examined by
fractionation of extracts prepared from Sss1Cp-expressing
cells. Not all of the Sss1p and Sss1Cp could be accounted for,
but the presence of some Sss1C protein in a cytosolic fraction
(Fig. 3A) suggests that the cytosolic domain of Sss1pmay not be
stably associated with the ER membrane in the absence of the
TM domain. The NSU and USC proteins were found in mem-
brane fractions, and both were found to be resistant to carbon-
ate extraction, demonstrating that they are stably membrane-
integrated (Fig. 3B).
Translocon Subunit Stability Is Unaffected by Sss1p Mutant
Protein Expression—The nonfunctionality of the Sss1p mutant
proteins could be explained if their expression resulted in the
destabilization of translocon components. Although overex-
pression of Sss1p can stabilize mutant Sec61p species (18),
depletion of Sss1pmight conversely destabilize Sec61p or com-
ponents of the larger heptameric SEC complex (19). This was
addressed by immunoblotting after depletion of Sss1p in vec-
tor-transformed FKY198 cells indicating no obvious reduction
in the expression levels of Sec61p, Sec62p, Sec63p, or Sbh1p
subunits (Fig. 2C, lanes 1 and 2). No reduction was observed
either in cells expressing the various Sss1p mutant proteins
(Fig. 2C, lanes 3–5). Therefore, Sss1p is not required to main-
tain the stability of the translocon subunits tested, and further-
more Sss1p mutant expression does not cause their instability.
NSUp Is Assembled into Sec61 Complexes—Although NSUp
is expressed at the same level as Sss1p (Fig. 2A) and does not
FIGURE 1. Sequence alignment of Sss1p/Sec61 homologs and the structure and function of Sss1p domain mutants. A, S. cerevisiae (Sc) Sss1p aligned
with its homologs from Schizosaccharomyces pombe (Sp), Neurospora crassa (Ns), Mus musculus (Mm), Homo sapiens (Hs), Canis familaris (Cf), and Caenorhabditis
elegans (Ce). Alignments were performed using CLUSTAL_X (16), with black, dark gray, and light gray shading representing 100%, 80%, and 60% amino acid
conservation. The TM domain (2) is underlined, and the highly conserved glycine residues are indicated by arrows. B, diagram of the Sec61-translocon in the ER
membrane as viewed from the back of the structure where the Sss1p TM domain is situated (see Ref. 1), illustrating the key features of the Sec61p-Sss1p
interface. The long curved TM domain of Sss1p has contacts with Sec61p TM domains 1, 5, 6, and 10 (numbered, behind the Sss1p TM in this view). The cytosolic
domain is orientated at 90° to its TM domain (direction of the arrow), having contact with the cytosolic loop between Sec61p TM 6 and 7 (6/7), and further
toward the N terminus is in close proximity to Sec61p TM9 (9, behind the 6/7 loop in this view). C, structure of Sss1p domain mutants. Sss1p (8.9 kDa) and Ubc6p
(28.3 kDa) are ER tail-anchored membrane proteins with TM sequences as indicated. The Sss1Cp (5.9 kDa) is truncated after residue Lys52 of Sss1p, and the
Sss112p (7.5 kDa) is truncated after residue Ile68. USCp (29.6 kDa) consists of the cytosolic domain of Ubc6p (Met1–Ser232) fused to the C-terminal region of
Sss1p (Ala53–Val80). NSUp (9.5 kDa) consists of the cytosolic domain of Sss1p (Met1–Lys52) fused to the TM of Ubc6p (Met233–Met249) with Sss1p residues
Lys69–Val80 at the C terminus. D, functional analysis of Sss1p domain mutants. Vector and plasmids encoding SSS1, the Sss1C, USC, and NSU mutants were
transformed into the SSS1 plasmid shuffle strain BWY530. All transformant strains grew normally after 3 days on minimal medium with selection for the SSS1,
URA3 plasmid (FKp53), and the HIS3 (pRS313)-transformed plasmids. After 3 days on 5-FOA containing minimal medium, the vector-only strain was unable to
grow due to the lethality of the sss1 mutation upon FKp53 counterselection, whereas the wild-type plasmid (SSS1) transformant grew by providing Sss1p
function. However, the Sss1Cp-, NSUp-, and USCp-encoding plasmids were unable to support growth, indicating the lethality of deletion and partial
substitution of the Sss1p TM domain and the substitution of the Sss1p cytosolic domain, respectively.
FIGURE 2. Expression of mutant Sss1p derivatives and SEC translocon
subunits. A, expression of Sss1p mutants. Whole cell extracts prepared from
FKY198 cells transformed with vector, wild-type SSS1 (WT), Sss1C, and NSU
plasmids grown in galactose (Glu) and after transfer to glucose medium
for 6 h (Glu) were subjected to 12.5% SDS-PAGE and immunoblot anal-
ysis with Sss1p antiserum. The panels were edited from the same immu-
noblot. B, whole cell extracts prepared from FKY198 cells after transfer to
glucose medium for 6 h bearing wild-type and USC plasmids as indicated
were analyzed by 10% SDS-PAGE and immunoblotting with Ubc6p anti-
serum. C, glucose-repressed extracts from above (A) were analyzed by
12.5% SDS-PAGE and immunoblotting with antiserum against Sec61p,
Sec62p, Sec63p, and Sbh1p as indicated. These data are representative of
two independent experiments.
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perturb translocon subunit stability (Fig. 2C), its phenotypes
could be explained by a failure to interact with Sec61p. This was
analyzed by utilizing the finding that the sole cysteine residue of
Sss1p which is located in the cytosolic domain (residue Cys39)
can form a disulfide bridge with a Sec61p species containing
three cysteine residues in TM9 (Sec61p-TM9C3). Yeast strain
CMY28, which expresses Sec61p-TM9C3 as the only source of
Sec61p and also expresses Sss1p under the control of a MET3
promoter, was transformed with control and NSUp-expressing
plasmids. Phenanthroline treatment of membranes from the
vector-transformed strain before Sss1p depletion or the SSS1
plasmid transformed strain after Sss1p depletion showed a
cross-link detected with both Sec61p and Sss1p antisera (Fig. 4,
lanes 2, 6, 10, and 14). This was absent upon Sss1p depletion in
the vector strain (Fig. 4, lanes 4 and 12). This Sec61p-Sss1p
cross-link is consistent with the close juxtaposition of the Sss1p
cytosolic domain and Sec61pTM9predicted by structural anal-
ysis (2, 3). A cross-link was also evident between NSUp and
Sec61p-TM9C3 (Fig. 4, lanes 8 and 16), demonstrating that
NSUp assembles into a complex with Sec61p.
Cytosolic and Transmembrane Domains of Sss1p Are Essen-
tial for Protein Translocation—The impact of deleting or sub-
stituting Sss1p domains on protein translocation was analyzed
after Sss1p depletion in cells expressing the various mutations.
Radiolabeled cell extracts of FKY198 transformants were
immunoprecipitated with antisera directed against ppCPY and
DPAP B, which are translocated by the post- and co-transla-
tional pathways, respectively (20). The accumulation of both
ppCPY and pDPAP B precursors upon Sss1p depletion con-
firmed the requirement for Sss1p in both translocation path-
ways (Fig. 5A, lane 3). Cells expressing Sss1Cp, NSUp, or
USCp were also found to accumulate both ppCPY and pDPAP
B precursors following Sss1p depletion (Fig. 5A, lanes 3–5),
thus showing that the cytosolic and TM domains of Sss1p are
essential for both the post- and co-translational modes of pro-
tein translocation.
Sss1p Is Required after Polypeptide Interaction with the
Translocon—The role played by Sss1p was further character-
ized by examining the targeting of secretory polypeptides to the
FIGURE 3. Membrane association of Sss1p domain mutants. A, FKY198
cells bearing the Sss1Cp plasmid were grown exponentially in galactose-
containing medium allowing expression of both Sss1p and Sss1Cp. These
cells were fractionated into crude cytosolic (C) and membrane (M) fractions.
2.0 A600 nm cell equivalents of each fraction and a total sample (T) were ana-
lyzed by 8 –16% SDS-PAGE and immunoblotting with Sss1p (upper panel) and
Sec63p (lower panel) antisera. The Sss1 protein and the ER integral membrane
protein Sec63p (17) were found largely in the membrane fraction (third lane)
as expected. However, some Sss1Cp was found in the cytosolic fraction
(second lane). B, membranes prepared from FKY198 cells transformed with
Sss1p (WT) NSUp- and USCp-expressing plasmids grown for 6 h in glucose
medium were subjected to carbonate extraction. Total (T), carbonate-soluble
(S), and carbonate-resistant pellet (P) samples were analyzed by 12.5% SDS-
PAGE and immunoblotted with antisera against Kar2p, Sec63p, and Sss1p
and Ubc6p as appropriate. Kar2p and Sec63p provide carbonate-extractable
and -resistant ER protein species, respectively (17). These data are represen-
tative of two independent experiments.
FIGURE 4. NSUp interaction with Sec61p. Membranes prepared from
CMY28 cells transformed with the pRS316-based SSS1/NSU plasmids or vec-
tor before (lanes 1, 2, 9, and 10) and after 10-h growth in 2 mM methionine
medium (lanes 3– 8, 11–16) were mock-treated or treated with 2 mM
Cu2(phe)3 (Phe). After 13% nonreducing SDS-PAGE, immunoblotting with
Sss1p (left panel) and reprobing of the same blot with Sec61p (right panel)
antiserum was performed. The adduct formed between Sec61p-TM9C3 and
Sss1p/NSUp is marked as x-link. These data are representative of two inde-
pendent experiments.
FIGURE 5. Protein translocation phenotypes of Sss1p domain mutants.
A, FKY198 cells containing control or Sss1p mutant plasmids were grown in
glucose medium for 6 h prior to 35S labeling for 5 min. Whole cell extracts
were immunoprecipitated with ppCPY- or DPAP B-specific antiserum, and the
precipitates were resolved by 10 and 7.5% SDS-PAGE, respectively (panels
edited from the same gels). Upon ER translocation, ppCPY is signal-cleaved
and modified by N-linked glycan addition in the ER (p1CPY) and the Golgi
(p2CPY). The type II membrane protein, DPAP B, acquires N-linked glycans
upon correct ER membrane integration. Tunicamycin (Tu) treatment yielded
signal-cleaved, but unglycosylated pro-CPY (lane 2) and the unglycosylated
pre-form of DPAP B (pDPAP B). B, post-translational translocation in vitro.
Membranes from FKY198 cells containing Sss1p (lane 1), vector (lane 2), or the
NSUp-expressing plasmids (lane 3) after 6 h in glucose were incubated with a
35S/TDBA-labeled K5/K14-ppf substrate, with visualization after 12.5% SDS-
PAGE. The 3gpf translocated and glycosylated form is indicated. C, analysis
of precursor targeting to Sec61p. Membranes prepared from FKY198 cells
containing Sss1p (WT) or the NSUp-expressing plasmids after 6 h of growth in
glucose medium were incubated with the 35S/TDBA-labeled K5/K14-ppf
after ATP-depletion. Two-thirds of each reaction was UV-irradiated, and
half of this was precipitated with Sec61p-specific antiserum. The reaction
products were visualized after 12.5% SDS-PAGE, and cross-links between
ppf and Sec61p are indicated (ppfxSec61p). Lane 1 contains radiola-
beled protein standards. The data in A and B are representative of two
independent experiments, and the data in C are representative of three
independent experiments.
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translocon. Initially, translocation competence in vitro was
tested using a ppf substrate containing photoreactive lysine
residues at positions 5 and 14 of the signal sequence (K5/K14-
ppf). Incubation of this substrate with wild-type membranes
generated the larger N-glycosylated 3gpf species, indicating
successful translocation (Fig. 5B, lane 1), whereas membranes
from NSUp-expressing cells were completely defective in
translocation (Fig. 5B, lane 2). These results demonstrate that
the Sss1p TM domain is also essential for protein translocation
in vitro. The same precursor was then used to assay translocon
targeting, by monitoring cross-linking to Sec61p under condi-
tions of ATP depletion, which prevents translocation to the ER
lumen after translocon targeting. In wild-type membranes, a
UV-dependent cross-linked adduct could be immunoprecipi-
tated with Sec61p antiserum (Fig. 5C, lane 4), consistent with
published data (15, 21). In the case of NSUmutantmembranes,
significant cross-linking of the ppf signal sequence to Sec61p
was also detected (Fig. 5B, lane 7) fromwhich we conclude that
the Sss1p TM domain is not essential for polypeptide targeting
to Sec61p.
Extreme C Terminus Is Essential for Sss1p Function—The
NSUp fusion contains 12 amino acid residues of the extreme C
terminus of Sss1p. The importance of this well conserved
region of Sss1p (Fig. 1A, residues Lys69–Val80) retained in the
NSUp fusionwas addressed by analyzing a truncated allele lack-
ing these residues (sss112). This allele was constructed by
integration of a kanMX6 termination cassette immediately
after the Ile68 codon of SSS1 in diploid strain W303-2n (see
“Experimental Procedures”). Haploid sss112 spores were only
obtained upon tetrad dissection in the presence of the SSS1,
URA3 plasmid FKp53. The viability of this mutation was then
checked by testing growth upon 5-FOA plasmid counterselec-
tion. It was found that the sss112 strain was unable to grow
upon 5-FOA counterselection of the wild-type SSS1 plasmid,
demonstrating that it is unable to provide Sss1p function (Fig.
6A). Expression of the truncated protein was examined in a
strain expressing SSS1 under the control of a MET3 promoter
both before and after methionine repression. The Sss1 protein
was found to be largely depleted bymethionine repression (Fig.
6B, lanes 2 and 4), but a faster migrating species corresponding
to the truncated Sss112p was specifically detected in the
sss112 strain only after Sss1p depletion (Fig. 6B, lane 4). This
indicates that Sss112p is only stable in the absence of Sss1p,
suggesting that the extreme C-terminal regionmay be required
for efficient interaction with Sec61p. Defects in the transloca-
tion of DPAP B and ppCPY were also detected in the Sss12p-
expressing strain after Sss1p depletion (Fig. 6, lane 5), indicat-
ing the requirement for the extreme C terminus of Sss1p in ER
translocation.
DISCUSSION
The Sss1 protein is an essential subunit of the ER protein
translocon, but its function has been poorly understood. In this
study we have analyzed the function of Sss1p by constructing a
series of mutant derivatives based on sequence conservation
and structural data. Particular attention has been paid to the
role of the Sss1pTMdomain, which has been shown to span the
membrane diagonally to clamp the pseudo-symmetrical halves
of Sec61p (2). Initially and somewhat surprisingly, mutation of
three highly conserved glycine residues in the Sss1p TM
domain did not result in growth or protein translocation
phenotypes. However, the analysis of yeast cells expressing
Sss1Cp demonstrated that deletion of the Sss1p TM resulted
in cell inviability and protein translocation defects. The Sss1C
protein did not co-fractionate with membranes, indicating the
requirement of the TM formembrane localization of Sss1p and
thus explaining the phenotypes associated with its deletion.
The possibility that the Sss1pTMdomain acts as a clampon the
Sec61 translocon and thus suggesting a function in addition to
that of amembrane anchor was analyzed by construction of the
NSU TM transplacement allele. The NSU protein was stably
membrane-integrated and maintained Sec61p interaction, but
could not suppress the lethality of thesss1mutation, and cells
expressing the protein were accordingly unable to translocate
secretory proteins across the ER membrane.
The Sss1p cytosolic domain was similarly analyzed by re-
placement with the topologically equivalent domain of Ubc6p
to yield the USC protein. As with NSUp, USCp was unable to
suppress the sss1 mutation, and cells expressing the protein
were deficient in ER protein translocation. This demonstrated
that the Sss1p cytosolic domain like the Sss1p TM domain is
FIGURE 6. Expression and phenotypes of the sss112 mutation. A, haploid
yeast strains bearing genomic wild-type SSS1, sss1, and sss112 alleles also
containing a SSS1, URA3 plasmid (FKp53) were grown on minimal medium
lacking uracil for plasmid selection and on 5-FOA medium for plasmid coun-
terselection for 3 days. All strains grew normally on minimal medium with
plasmid selection. After 3 days on 5-FOA medium, the wild-type strain grew as
expected, and the sss1 strain was lethal upon plasmid counterselection as
expected. The sss112 strain was also unable to grow on this medium, indi-
cating the lethality of removing the C-terminal 12 residues of Sss1p. B, whole
cell extracts prepared from the MET3-SSS1 strains BWY875 (sss1) and
BWY886 (sss112) grown in minimal medium without methionine or in the
presence of 2 mM methionine for 8 h (to deplete Sss1p) were subjected to 16%
SDS-PAGE and immunoblot analysis with Sss1p antiserum. C, strains BWY875
and BWY886 grown as above were labeled with 14C-amino acids for 5 min.
The sample in lane 1 was provided by BWY875 cells grown in the absence of
methionine and treated with tunicamycin (Tu). Whole cell extracts were then
immunoprecipitated with ppCPY- or DPAP B-specific antiserum, and the pre-
cipitates were resolved by 10 and 7.5% SDS-PAGE, respectively. For a descrip-
tion of ppCPY and DPAP B ER processing, see Fig. 5 legend. The data in B and
C are representative of two independent experiments.
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also essential for Sss1p function, cell viability, and protein
translocation. The ability of NSUp to interact with Sec61p also
strongly indicates a key role for the Sss1p cytosolic domain in
the assembly of Sss1p into the translocon. Analysis of the
Sss112p truncation showed that the extreme C terminus of
Sss1p retained inNSUp is also essential for Sss1p function. This
region of Sss1p is proposed to interact with the luminal end of
Sec61pTM1, and thus this interactionmay play a key role in the
assembly of the functional translocon. The oxidative cross-
linking observed between the Sss1p cytosolic domain and the
cytosolic end of Sec61p TM9 is in agreement with structural
data (2, 3). The depletion of Sss1p or the expression of domain
mutations did not result in the instability of other translocon
subunits. It is therefore concluded that the observed lethality
and translocation defects are a direct reflection of the role
played by Sss1p in ER protein translocation.
This study shows that the cytosolic and TM clamp domains
of Sss1p are required for both the post- and co-translational
modes of translocation in vivo. This strongly suggests that both
domains are required at a crucial step during protein translo-
cation irrespective of the mode of precursor targeting. This
rules out roles in Signal Recognition Particle receptor or ribo-
some binding, and indeed, the structures of Sec61 complexes
bound to nontranslating and translating ribosomes have not
suggested any specific contacts with the -subunit of the trans-
locon (22, 23). Sss1p-depleted membranes were found to be
completely defective in the translocation of ppf in vitro, con-
sistent with the severe translocation phenotypes evident upon
Sss1p depletion in vivo found in this study and in a previous
report (4). NSUp-containing membranes were also unable to
translocate ppf in vitro. However, intriguingly, it was found
that ppf polypeptides were targeted efficiently to Sec61p in
NSUp-containing membranes as detected by photocross-link-
ing analysis. These findings indicate that the key role of Sss1p
occurs after signal sequence targeting to the translocon.
Evidence has emerged that signal sequence insertion into the
translocon channel leads to displacement of the plug domain
and partial opening of the lateral gate (23–25). Our data dem-
onstrate that signal sequence targeting to Sec61p can be com-
pleted in NSUp membranes from which we can conclude that
the clamp domain is not essential for this initial targeting step.
However, translocation cannot progress beyond this stage, and
so the clamp domain is required to activate the precursor-
translocon complex to initiate polypeptide translocation. The
simplest model that would account for our results would
involve a rearrangement of the Sss1p transmembrane clamp
domain relative to the hinge domain within Sec61p that would
promote lateral opening of the channel to allow the transloca-
tion substrate to fully access the translocon channel. Such a
model would enable translocation to proceed and would give
Sss1p an important role in restricting channel opening to pre-
vent lipid flooding and perhaps to restrict small molecule leak-
age. Interestingly, structural models predict that as the lateral
gate opens, the -subunit TM 7, 8, and 9 domains would move
outward, with TM9 in close proximity to the -subunit cytoso-
lic domain (24). Our cross-linking data support this model
becausewe see very efficient cross-linking between specific cys-
teine residues in TM9 of Sec61p with the cytosolic domain of
Sss1p. Thus, then the two domains of Sss1p would act co-ordi-
nately to complete channel opening and translocon activation.
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